Meet Kalms Group at DMEA 2026 In Berlin
Kalms Group will be present at DMEA 2026 and available for meetings in Berlin.
As an integrated advisory and operations partner, Kalms Group combines regulatory and reimbursement expertise with operational execution, supporting Medical Device Manufacturers, Digital Health Companies, and Investors in structuring compliant market entry pathways and building sustainable operations in Europe.
During DMEA 2026, we look forward to discussing:
- MDR and IVDR compliance strategies and transition planning
- Market access, reimbursement and commercialization strategies in Germany and across the EU
- Digital health positioning under evolving EU regulatory and data frameworks
- Artificial intelligence in medical devices and regulatory alignment
- Quality Management Systems (QMS) optimization under European and international standards
- Importer, Authorized Representative, and EU distribution structures
- Third-party logistics (3PL), warehousing, and healthcare supply chain setup
- Clinical trial logistics and cross-border coordination
- Field Service Engineering and technical support in Europe
With decades of combined experience and a strong international partner network, Kalms Group supports MedTech, digital health, and BioTech companies throughout the full lifecycle – from regulatory and market access strategy to logistics, operational execution, and sustainable expansion in Europe.
If you will be attending DMEA 2026 and would like to arrange a meeting in advance, please contact us at info@kalmsconsulting.com.
About DMEA 2026
The European healthcare and MedTech landscape continues to evolve under the implementation of MDR and IVDR, the upcoming mandatory use of EUDAMED modules, increasing cybersecurity expectations, reimbursement challanges, and developments related to the European Health Data Space (EHDS). These factors are influencing how companies approach regulatory compliance, market entry, and operational planning across the EU.
At the same time, topics such as artificial intelligence, interoperability, and hospital IT modernization remain central to digital health strategies in the DACH region and across Europe. For medical device manufacturers as well as digital health companies, regulatory approval must be aligned with structured market access planning, reimbursement strategy, and operational readiness.
DMEA 2026, taking place from 21 to 23 April 2026 in Berlin, is one of Europe’s leading events for digital health. It brings together stakeholders from MedTech, digital health, healthcare institutions, regulatory bodies, and service providers to discuss current developments and future directions in healthcare delivery.
We look forward to connecting with you in Berlin and discussing your plans, challenges, and growth ambitions!
The image utilized in this article was sourced from unsplash.com in accordance with the license terms of use.
Published on: April 7, 2026
